Alzheimer’s Disease Related Biomarkers Were Associated with Amnestic Cognitive Impairment in Parkinson’s Disease: A Cross-Sectional Cohort Study
Brain Sciences · 02.08.2024 · 14 (8) · 787
DOI: 10.3390/brainsci14080787 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Brain Sciences, online erschienen am 02.08.2024. Verfasst von Xiaofan Xue und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Cognitive impairment is common in patients with Parkinson’s disease (PD) and occurs through multiple mechanisms, including Alzheimer’s disease (AD) pathology and the involvement of α-synucleinopathies. We aimed to investigate the pathological biomarkers of both PD and AD in plasma and neuronal extracellular vesicles (EVs) and their association with different types of cognitive impairment in PD patients.
Methods
A total of 122 patients with PD and 30 healthy controls were included in this cross-sectional cohort study between March 2021 and July 2023. Non-dementia PD patients were divided into amnestic and non-amnestic groups according to the memory domain of a neuropsychological assessment. Plasma and neuronal EV biomarkers, including α-synuclein (α-syn), beta-amyloid (Aβ), total tau (T-tau), phosphorylated tau181 (p-tau181), and glial fibrillary acidic protein (GFAP), were measured using a single-molecule array and a chemiluminescence immunoassay, respectively.
Results
Neuronal EV but not plasma α-syn levels, were significantly increased in PD as compared to healthy controls, and they were positively associated with UPDRS part III scores and the severity of cognitive impairment. A lower plasma Aβ42 level and higher neuronal EV T-tau level were found in the amnestic PD group compared to the non-amnestic PD group.
Conclusions
The results of the current study demonstrate that neuronal EV α-syn levels can be a sensitive biomarker for assisting in the diagnosis and disease severity prediction of PD. Both AD and PD pathologies are important factors in cognitive impairment associated with PD, and AD pathologies are more involved in amnestic memory deficit in PD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
- Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100043, China.
- Department of Neurology, The People's Hospital of Shijiazhuang, Shijiazhuang 050000, China.
- Department of Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
- National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing 100053, China.
- Parkinson's Disease Cloud Medical Technology Company, Beijing 100055, China.
ORCID-Profile: Xiaofan Xue
Zitieren
APA
Xue, X., Mei, S., Huang, A., Wu, Z., Zeng, J., Song, H., An, J., Zhang, L., Liu, G., Zhou, L., Cai, Y., Xu, B., Xu, E., & Chan, P. (2024). Alzheimer’s Disease Related Biomarkers Were Associated with Amnestic Cognitive Impairment in Parkinson’s Disease: A Cross-Sectional Cohort Study. Brain Sciences, 14(8), 787. https://doi.org/10.3390/brainsci14080787
Vancouver
Xue X, Mei S, Huang A, Wu Z, Zeng J, Song H, et al. Alzheimer’s Disease Related Biomarkers Were Associated with Amnestic Cognitive Impairment in Parkinson’s Disease: A Cross-Sectional Cohort Study. Brain Sciences. 2024;14(8):787. doi:10.3390/brainsci14080787
BibTeX
@article{Xue2024,
author = {Xue, Xiaofan and Mei, Shanshan and Huang, Anqi and Wu, Zhiyue and Zeng, Jingrong and Song, Haixia and An, Jing and Zhang, Lijuan and Liu, Guozhen and Zhou, Lichun and Cai, Yanning and Xu, Baolei and Xu, Erhe and Chan, Piu},
title = {Alzheimer’s Disease Related Biomarkers Were Associated with Amnestic Cognitive Impairment in Parkinson’s Disease: A Cross-Sectional Cohort Study},
journal = {Brain Sciences},
year = {2024},
volume = {14},
number = {8},
pages = {787},
doi = {10.3390/brainsci14080787}
}
EUVIMED